Učitavanje...
Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
BACKGROUND: The survival benefit of neoadjuvant therapy in resectable carcinoma esophagus has been elucidated. We performed a meta-analysis in light of new studies and long-term results of past trials. The search strategy was refined to include only “neoadjuvant” so that any bias by adjuvant treatme...
Spremljeno u:
| Izdano u: | World J Surg Oncol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085863/ https://ncbi.nlm.nih.gov/pubmed/32199464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-01830-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|